Basic HTML Version
19
Anna Tomaszuk-Kazberuk i wsp.,
Dializy ratują życie, ale niszczą serce
www.chsin.viamedica.pl
24. Abe S., Yoshizawa M., Nakanishi N. i wsp. Electrocardiographic abnormalities
in patients receiving hemodialysis.
Am. Heart J.
1996; 131: 1137–1144.
25. Engel G., Beckerman J., Froelicher V. i wsp. Electrocardiographic arrhythmia risk
testing.
Curr. Probl. Cardiol.
2004; 29: 365–432.
26. Shapira O.M., Bar-Khayim Y. ECG changes and cardiac arrhythmias in chronic
renal failure patients on hemodialysis.
J. Electrocardiol
. 1992; 25: 273–279.
27. Krane V., Heinrich F., MeesmannM. i wsp. Electrocardiography and outcome in
patients with diabetes mellitus on maintenance hemodialysis.
Clin. J. Am. Soc.
Nephrol.
2009; 4: 394–400 (Epub 2009 Jan 21).
28. Jaroszyński A. Nieinwazyjne metody oceny ryzyka nagłej śmierci sercowej
u chorych dializowanych.
Nefrol. Nadciś. Tętn.
2010; 41: 93–103.
29. K/DOQI clinical practiceguidelines for cardiovascular disease indialysispatients.
Am. J. Kidney Dis.
2005; 45 (supl. 3): S1.
30. Sharma R., Pellerin D., Gaze D.C. i wsp. Dobutamine stress echocardiography
and cardiac troponin T for the detection of significant coronary artery disease
and predicting outcome in renal transplant candidates.
Eur. J. Echocardiogr.
2005; 6: 327–335.
31. Feringa H.H., Bax J.J., SchoutenO. i wsp. Ischemic heart disease in renal trans-
plant candidates: towards non-invasive approaches for preoperative risk strati-
fication.
Eur. J. Echocardiogr.
2005; 6: 313–316.
32. SharmaR., PellerinD., GazeD. i wsp. Dobutamine stress echocardiography and
the resting but not exercise electrocardiograph predict severe coronary artery
disease in renal transplant candidates.
Nephrol. Dial. Transplant.
2005; 20: 2207–
–2214.
33. Elsner D. How to diagnose and treat coronary artery disease in the uraemic pa-
tient: an update.
Nephrol. Dial. Transplant.
2001; 16: 1103–1108.
34. Sobkowicz B., Tomaszuk-Kazberuk A., Malyszko J. i wsp. Value of the real-time
myocardial contrast echocardiography for risk stratification and for the detec-
tion of significant coronary stenosis in patients with end-stage renal disease.
Nephrol. Dial. Transplant.
2007; 22: 668–669.
35. Sobkowicz B., Tomaszuk-Kazberuk A., Kralisz P. i wsp. Application of myocar-
dial contrast echocardiography for theperfusionassessment inpatientswithend-
-stage renal failure — comparison with coronary angiography.
Am. J. Nephrol.
2008; 28: 929–934.
36. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular di-
sease in dialysis patients.
Am. J. Kidney Dis.
2005; 45 (supl. 3): S1–S153.
37. Sedlis S.P., Jurkovitz C.T., Hartigan P.M. i wsp. COURAGE Study Investigators.
Optimal medical therapy with or without percutaneous coronary intervention for
patients with stable coronary artery disease and chronic kidney disease.
Am.
J. Cardiol.
2009; 104: 1647–1653.
38. ReddanD.N., Szczech L.A., Tuttle R.H. i wsp. Chronic kidney disease, mortality,
and treatment strategies among patients with clinically significant coronary ar-
tery. disease.
J. Am. Soc. Nephrol.
2003; 14: 2373–2380.
39. Hemmelgarn B.R., Southern D., Culleton B.F. i wsp. Alberta Provincial Project
for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investiga-
tors. Survival after coronary revascularization among patients with kidney dise-
ase.
Circulation
2004; 110: 1890–1895.
40. Trespalacios F.C., Taylor A.J., Agodoa L.Y., Abbott K.C. Incident acute corona-
ry syndromes in chronic dialysis patients in the United States.
Kidney Int.
2002;
62: 1799–1805.
41. Herzog C.A., Ma J.Z., Collins A.J. Poor long-term survival after acute myocar-
dial infarction amongpatients on long-termdialysis.
NewEngl. J. Med.
1998; 339:
799–805.
42. Surana S.P., Riella L.V., Keithi-Reddy S.R. i wsp. Acute coronary syndrome in
ESRD patients.
Kidney Int.
2009; 75: 558–562.
43. Charytan D., Mauri L., Agarwal A. i wsp. The use of invasive cardiac procedures
after acutemyocardial infarction in long-termdialysis patients.
Am. Heart J.
2006;
152: 558–564.
44. Herzog Ch.A., Littrell K., Arko Ch. i wsp. Clinical characteristics of dialysis pa-
tients with acute myocardial infarction in the United States. A Collaborative Pro-
ject of theUnitedStates Renal Data Systemand theNational Registry of Myocar-
dial Infarction.
Circulation
2007; 116: 1465–1472.
45. Krane V., Heinrich F., MeesmannM. i wsp. German Diabetes andDialysis Study
Investigators. Electrocardiography and outcome in patients with diabetes mel-
litus onmaintenance hemodialysis.
Clin. J. Am. Soc. Nephrol.
2009; 4: 394–400.
46. ChewH.C. Cardiac troponin T in acute coronary syndromewith renal insufficien-
cy.
Asian Cardiovasc. Thorac. Ann.
2008; 16: 284–287.
47. Stolear J., Georges B., Shita A., VerbeelenD. The predictive value of cardiac tro-
ponin Tmeasurements in subjects on regular hemodialysis
. Nephrol. Dial. Trans-
plant.
1999; 14: 1961–1967.
48. WayandD., BaumH., SchatzleG., Scharf J., Neumeier D. Cardiac troponin T and
I in end-stage renal failure.
Clin. Chem.
2000; 46: 1345–1350.
49. Ooi D., Veinot J.,WellsG., HouseA. Increasedmortality in hemodialyzedpatients
with elevated serum troponin T.
Clin. Biochem.
1999; 32: 647–652.
50. Roppolo L., Fitzgerald R., Dillow J. i wsp. A comparison of troponin T and tropo-
nin I as predictors of cardiac events in patients undergoing chronic dialysis at
a veteran’s hospital: a pilot study.
J. Am. Coll. Cardiol.
1999; 34: 448–454.
51. Dierkes J., Domrose U., Westphal A. i wsp. Cardiac troponin T predictsmortality
in patients with end-stage renal disease.
Circulation
2000; 102: 1964–1969.
52. Mallamaci F., Zoccali C., Parlongo S. i wsp. Troponin is related to left ventricular
mass and predicts all-causemortality and cardiovascular mortality in hemodia-
lysis patients.
Am. J. Kidney Dis.
2002; 40: 68–75.
53. Apple F., Murakami M., Pearce L., Herzog C. Predictive value of cardiac tropo-
nin I and T for subsequent death in end-stage renal disease.
Circulation
2002;
106: 2941–2945.
54. Willging S., Keller F., Steinbach G. Specificity of cardiac troponins I and T in re-
nal disease.
Clin. Chem. Lab. Med.
1998; 36: 87–92.
55. Aviles R.J., Askari A.T., Lindahl B. i wsp. Troponin T levels in patients with acute
coronary syndromes, with or without renal dysfunction.
N. Engl. J. Med.
2002;
346: 2047–2052.
56. RyuD.R., Park J.T., Chung J.H. i wsp. Amore appropriate cardiac troponin T level
that can predict outcomes in end-stage renal disease patients with acute coro-
nary syndrome.
Yonsei Med. J.
2011; 52: 595–602.
57. Mallamaci F., Zoccali C., Parlongo S. i wsp. Cardiovascular risk extended eva-
luation in dialysis investigators. Diagnostic value of troponin T for alterations in
left ventricular mass and function in dialysis patients.
Kidney Int.
2002; 62: 1884–
–1890.
58. Brunet P., Oddoze C., Paganelli F. i wsp. Cardiac troponins I and T in hemodialy-
sis patientswithout acute coronary syndrome.
Int. J. Cardiol.
2008; 129: 205–209.
59. Tun A., Khan I.A., Win M.T. i wsp. Specificity of cardiac troponin I and creatine
kinase-MB isoenzyme in asymptomatic long-termhemodialysis patients and ef-
fect of hemodialysis on these cardiac markers.
Cardiology
1998; 90: 280–285.
60. Charytan D.M., Wallentin L., Lagerqvist B. i wsp. Early angiography in patients
with chronic kidney disease: a collaborative systematic review.
Clin. J. Am. Soc.
Nephrol.
2009; 4: 1032–1043.
61. McCullough P.A. Acute coronary syndromes in patients with renal failure.
Curr.
Cardiol. Rep.
2003; 5: 266–270.
62. ChertowG.M., Normand S.L., McNeil B.J. “Renalism”: inappropriately low rates
of coronary angiography in elderly individualswith renal insufficiency.
J. Am. Soc.
Nephrol.
2004; 15: 2462–2468.
63. Keeley E.C., KadakiaR., Soman S., Borzak S., McCullough P.A. Analysis of long-
-termsurvival after revascularization in patients with chronic kidney disease pre-
senting with acute coronary syndromes.
Am. J. Cardiol.
2003; 92: 509–514.
64. Zipes D.P., Camm A.J., Borggrefe M. i wsp. American College of Cardiology/
/AmericanHeart Association Task Force; European Society of Cardiology Com-
mittee for PracticeGuidelines; EuropeanHeart RhythmAssociation and theHeart
RhythmSociety. ACC/AHA/ESC2006guidelines formanagement of patientswith
ventricular arrhythmias and the prevention of sudden cardiac death—executi-
ve summary: a report of the American College of Cardiology/American Heart
Association Task Force and the European Society of Cardiology Committee for
PracticeGuidelines (WritingCommittee toDevelopGuidelines for Management
of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac
Death) Developed in collaborationwith the EuropeanHeart RhythmAssociation
and the Heart Rhythm Society.
Eur. Heart J.
2006; 27: 2099–2114.
65. Foley R.N., Parfrey P.S., Harnett J.D. i wsp. Clinical and echocardiographic di-
sease in patients starting end-stage renal disease therapy.
Kidney Int.
1995; 47:
186–192.
66. Paoletti E., Specchia C., Di Maio G. i wsp. The worsening of left ventricular hy-
pertrophy is the strongest predictor of sudden cardiac death in haemodialysis
patients: a 10 years survey.
Nephrol. Dial. Transplant.
2004; 19: 1829–1834.